<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Chowdhury A</submitter><funding>Australian Research Council</funding><pubmed_abstract>African spitting cobras are unique among cobras for their potent anticoagulant venom activity arising from strong inhibition of Factor Xa. This anticoagulant effect is exerted by venom phospholipase A&lt;sub>2&lt;/sub> (Group I PLA&lt;sub>2&lt;/sub>) toxins whose activity contributes to the lethality of these species. This anticoagulant toxicity is particularly problematic as it is not neutralized by current antivenoms. Previous work demonstrated this trait for &lt;i>Naja mossambica, N. nigricincta&lt;/i>, &lt;i>N. nigricollis&lt;/i>, and &lt;i>N. pallida.&lt;/i> The present work builds upon previous research by testing across the full taxonomical range of African spitting cobras, demonstrating that &lt;i>N. ashei&lt;/i>, &lt;i>N. katiensis&lt;/i>, and &lt;i>N. nubiae&lt;/i> are also potently anticoagulant through the inhibition of Fact</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>752442</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8529177</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (&lt;i>Naja&lt;/i> Species) Venoms.</pubmed_title><pmcid>PMC8529177</pmcid><pubmed_authors>Fry BG</pubmed_authors><pubmed_authors>Chowdhury A</pubmed_authors><pubmed_authors>Carter R</pubmed_authors><pubmed_authors>Lewin MR</pubmed_authors><pubmed_authors>Zdenek CN</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (&lt;i>Naja&lt;/i> Species) Venoms.</name><description>African spitting cobras are unique among cobras for their potent anticoagulant venom activity arising from strong inhibition of Factor Xa. This anticoagulant effect is exerted by venom phospholipase A&lt;sub>2&lt;/sub> (Group I PLA&lt;sub>2&lt;/sub>) toxins whose activity contributes to the lethality of these species. This anticoagulant toxicity is particularly problematic as it is not neutralized by current antivenoms. Previous work demonstrated this trait for &lt;i>Naja mossambica, N. nigricincta&lt;/i>, &lt;i>N. nigricollis&lt;/i>, and &lt;i>N. pallida.&lt;/i> The present work builds upon previous research by testing across the full taxonomical range of African spitting cobras, demonstrating that &lt;i>N. ashei&lt;/i>, &lt;i>N. katiensis&lt;/i>, and &lt;i>N. nubiae&lt;/i> are also potently anticoagulant through the inhibition of Fact</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-20T02:04:44.418Z</modification><creation>2025-04-20T02:04:44.418Z</creation></dates><accession>S-EPMC8529177</accession><cross_references><pubmed>34691069</pubmed><doi>10.3389/fimmu.2021.752442</doi></cross_references></HashMap>